+0.201 (+3.72%)
Range 5.410 - 5.950   (9.98%)
Open 5.500
Previous Close 5.400
Buy Price 5.580
Buy Volume 10
Sell Price 5.600
Sell Volume 9
Volume 1,622,496
Value -
Measurement Type Value
EPS (USD) -0.451
Trailing EPS (USD) -0.524
NAV (USD) 0.819
Cash In Hand (USD) 0.859
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 6.595
Price / Cash In Hand 6.289
Issued & Paid-up Shares 14,130,100
Treasury Shares -
Market Cap (M) 76.303
Par Value (USD) n.a.
Beta - 75 Days 1.05
R-Squared - 75 Days(%) -
Beta - 500 Days 1.398
R-Squared - 500 Days(%) 0.08
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 25 Jun 2021 01:47.
Data powered by

Upcoming Events

* Stock event date based on US timezone.


Release Date 24 Jun 2021
View All Events


Aethlon Medical, Inc. is a medical device company, which creates medical devices to address unmet therapeutic needs in infectious disease, cancer and other life-threatening conditions. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are secreted by tumors to prevent the immune system from rejecting the tumors. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based products to diagnose and monitor neurological disorders and cancer. Additionally, the Company operates under two Department of Defense contracts related to a program entitled Dialysis-Like Therapeutics.

Loading Chart...